investorscraft@gmail.com

Intrinsic value of MEDIFAST INC (MED)

Previous Close$138.78
Intrinsic Value
Upside potential
Previous Close
$138.78

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh1762.64 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through direct ecommerce platform and franchise weight control center channels. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %63.2NaN
Revenue, $1526NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1310NaN
Operating income, $m216NaN
EBITDA, $m228NaN
Interest expense (income), $mNaN
Earnings before tax, $m216NaN
Tax expense, $m52NaN
Net income, $m164NaN

BALANCE SHEET

Cash and short-term investments, $m110NaN
Total assets, $m412NaN
Adjusted assets (=assets-cash), $m303NaN
Average production assets, $m59NaN
Working capital, $m137NaN
Total debt, $m33NaN
Total liabilities, $m210NaN
Total equity, $m202NaN
Debt-to-equity ratio0.161NaN
Adjusted equity ratio0.328NaN

CASH FLOW

Net income, $m164NaN
Depreciation, amort., depletion, $m12NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m95NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-34NaN
Free cash flow, $m129NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m137
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount